Omnicell (OMCL) Change in Receivables (2010 - 2026)
Omnicell's (OMCL) quarterly Change in Receivables came in at -$23.1 million in Q2 2026, down 13.73% year-over-year from -$26.8 million in Q2 2025, and down 169.39% quarter-over-quarter from $33.3 million in Q1 2026.
Analysis
Omnicell (OMCL) Change in Receivables (2010 - 2026) Analysis & Trends
Omnicell (OMCL) has reported Change in Receivables for 17 consecutive years, with -$23.1 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Change in Receivables fell 13.73% year-over-year to -$23.1 million in Q2 2026; TTM through Jun 2026 was -$5.4 million, a 46.12% increase from a year earlier, with the FY2025 full-year figure at -$41.4 million, down 928.15% from the prior year.
- Change in Receivables was -$23.1 million for Q2 2026 at Omnicell, down from $33.3 million in the prior quarter.
- Over five years, Change in Receivables peaked at $50.0 million in Q1 2022 and troughed at -$56.5 million in Q4 2022.
- A 5-year average of -$834555.6 and a median of -$2.0 million in 2023 frame the typical range for Change in Receivables.
- Across the five-year window, Change in Receivables tumbled 4104.11% in 2022 and surged 1756.56% in 2024, its largest moves.
- Over 5 years, Change in Receivables stood at -$56.5 million in 2022, then soared by 60.91% to -$22.1 million in 2023, then jumped by 127.95% to $6.2 million in 2024, then slumped by 569.14% to -$29.0 million in 2025, then increased by 20.25% to -$23.1 million in 2026.
- The last three Change in Receivables figures came in at -$23.1 million (Q2 2026), $33.3 million (Q1 2026), and -$29.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 74.90 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | -224.00 Mn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 177.00 Mn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 46.00 Mn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 10.20 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | - |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 172.10 Mn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | 37.21 Mn |
| 10 | Omnicell | 1.57 Bn | 1.28 Bn | 152.94 Mn | -23.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -23.11 Mn |
| Mar 31, 2026 | 33.30 Mn |
| Dec 31, 2025 | -28.97 Mn |
| Sep 30, 2025 | 13.41 Mn |
| Jun 30, 2025 | -20.32 Mn |
| Mar 31, 2025 | -5.55 Mn |
| Dec 31, 2024 | 6.18 Mn |
| Sep 30, 2024 | 9.72 Mn |
| Jun 30, 2024 | -7.51 Mn |
| Mar 31, 2024 | -3.39 Mn |
| Dec 31, 2023 | -22.10 Mn |
| Sep 30, 2023 | -587,000.00 |
| Jun 30, 2023 | -48.62 Mn |
| Mar 31, 2023 | 22.16 Mn |
| Dec 31, 2022 | -56.54 Mn |
| Sep 30, 2022 | 45.48 Mn |
| Jun 30, 2022 | 21.42 Mn |
| Mar 31, 2022 | 49.99 Mn |
| Dec 31, 2021 | 1.41 Mn |
| Sep 30, 2021 | 19.90 Mn |